Environmental, Social and Governance (ESG)
We believe transparency is best practice for everyone:
Luye Pharma Ltd is committed in ensuring transparency of relationships with Healthcare Professionals (HCPs), Healthcare Organisations (HCOs), and other relevant decision makers (ORDMs) by operating within the Association of British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on Disclosure on Transfers of Value.
These partnerships focus on the exchange of knowledge and expertise, that we believe it is crucial to ensure that patients receive the highest standard of care.
ABPI Statement
Statement – Annual Disclosure under ABPI Code, of Payments made by Luye in the Year 2024
Find Out More
Carbon Reduction Plan
We are committed to achieving Net Zero emissions by 2050 and are working towards limiting carbon emissions during our expansion in the UK market.
Find Out More